Last month, the Office of the United States Trade Representative (USTR) released its 2018 Special 301 Report (the Report), identifying trading partners that do not adequately or effectively protect and enforce intellectual property (IP) rights or otherwise deny market access …
Brazilian Mailbox Patents: Big Loss for Alexion
On April 20, 2018, Alexion Pharmaceutical Inc.’s (Alexion) patent (PI9507594-1) covering Soliris® (eculizumab) was the subject of an unfavorable decision by the Superior Court of Justice involving the term of mailbox patents in Brazil. Soliris® (eculizumab) is a humanized antibody …
Patent Term Extension is Becoming a Reality in China
On April 12, 2018, the state council of China announced that beginning May 1, 2018, a maximum of 5-year patent term extension will be available for innovative drugs (commonly referred to as branded drugs) seeking market approval within and outside …
Read More "Patent Term Extension is Becoming a Reality in China"
Protecting Life Science Inventions in the Arabian Gulf States – Part 1: Saudi Arabia
Bahrain, Iraq, Kuwait, Oman, Qatar, Saudi Arabia and the United Arab Emirates comprise what is known as the Arab States of the Arabian Gulf or “Gulf States”. Six of these seven countries, the exception being Iraq, form part of the …
Read More "Protecting Life Science Inventions in the Arabian Gulf States – Part 1: Saudi Arabia"
